ASTRAZENECA PHARMA INDIA LTD. - Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we wish to inform the below: 1. Based on the recommendation of the Nomination & Remuneration Committee meeting, the Board of Directors have appointed Ms. Monica Widhani (DIN: 07674403) as an Additional Director (Independent) on the Board of the Company, with effect from September 25, 2024. 2. Mr. Narayan. K. Seshadri (DIN: 053563), Independent Director of the Company, will retire as Director of the Company upon completion of his term of office, at the close of business hours on September 29, 2024. 3. Ms. Shipla Divekar Nirula, Independent Director has been unanimously elected as Chairperson of the Board. Please find enclosed the letter in this regard.